Peer-reviewed veterinary case report
Effects of indinavir in a preliminary phase I study on dogs with stage III slenic hemangiosarcoma.
- Journal:
- In vivo (Athens, Greece)
- Year:
- 2006
- Authors:
- Spugnini, Enrico P et al.
- Affiliation:
- SAFU Department · Italy
- Species:
- dog
Abstract
HIV protease inhibitors are antiretroviral drugs able to prevent production of infectious particles. It has been shown that these protease inhibitors are able to inhibit cancer-promoted angiogenesis in patients affected by Kaposi's sarcoma. A preliminary phase I study on dogs with stage III splenic hemangiosarcoma was designed in order to evaluate the efficacy and toxicity of the protease inhibitor Indinavir to delay the progression of this advanced neoplasm. The results suggest that Indinavir is potentially beneficial in dogs affected by microscopic residual disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/16433040/